The Phillies got exactly what they paid for out of Brad Keller for about three months. Then his elbow gave out, and now Philadelphia is staring down a bullpen problem it didn't budget for heading into deadline week.
Mark Feinsand confirmed the surgery details and the brutal recovery window.
Two NL health updates: The Dodgers have activated Edwin Diaz from the IL. The Phillies announced that Brad Keller underwent right elbow ulnar collateral ligament reconstruction with internal brace and flexor tendon repair surgery. Timeline to return is 13-16 months.
Keller went under the knife on July 29 for right elbow UCL reconstruction, and it wasn't a standard Tommy John — he also needed an internal brace and flexor tendon repair, per Feinsand's report. That combo procedure typically means an even more cautious recovery, and the 13-to-16-month runway puts a realistic return somewhere in the back half of the 2027 season, if not further out.
This one stings extra because of how the Keller signing was supposed to play out. He landed in Philadelphia on a two-year, $22 million deal over the winter after posting a 2.07 ERA across 69.2 innings with the Cubs in 2025, a bounce-back that came after he'd already had thoracic outlet syndrome surgery back in 2023. The Phillies bet on him settling into a high-leverage bullpen role, and for a stretch he delivered — 13 holds, three saves and a 4.02 ERA in 31.1 innings before the elbow started barking.
MLB Trade Rumors laid out the same UCL diagnosis and surgical outcome.
The tear was actually first flagged around the All-Star break, and the surgery Tuesday confirmed the worst-case outcome instead of a rehab-and-see approach. For a pitcher who's already battled one major arm surgery, a second lengthy shoulder-to-elbow rebuild is the kind of thing that can quietly end a career, or at least make the back half of that contract look like dead money.
Practically speaking, this just adds another name to the Phillies' growing list of bullpen questions right as the trade deadline closes in. Philadelphia already had reasons to be shopping for relief help; now it's not a luxury, it's a necessity, and Keller's spot in high-leverage innings needs to be filled by committee or by outside addition. The financial hit is real too — burning through a chunk of a $22 million commitment on a guy who might not throw a competitive pitch again until deep into next season is exactly the kind of thing that makes front offices gun-shy on future reliever deals.
For now it's a watch-and-wait situation. Keller's recovery clock effectively wipes out 2027 as a realistic year for him, leaving the Phillies to figure out their bullpen math without him for the foreseeable future.